• Corpus ID: 8927703

[Antibiotics and bacterial resistance].

@article{Levaditi1953AntibioticsAB,
  title={[Antibiotics and bacterial resistance].},
  author={C. Levaditi and J. Henry-Eveno},
  journal={Annales de l'Institut Pasteur},
  year={1953},
  volume={85 1},
  pages={
          108-12
        }
}
Remedial Aspect of Zinc Oxide Nanoparticles Against Serratia Marcescens and Enterococcus Faecalis
TLDR
The growth-inhibitory test demonstrated a dose-dependent growth inhibitory effect of ZnO NPs against both the test bacteria, as the higher concentration of nanoparticles caused the higher bacterial growth inhibition.
Mycoplasmas as Host Pantropic and Specific Pathogens: Clinical Implications, Gene Transfer, Virulence Factors, and Future Perspectives
TLDR
This review covers clinical implications of mycoplasmas in humans and domestic and wild animals, virulence-related factors, the process of gene transfer and its crucial prospects, the current application and future perspectives of nanotechnology for diagnosing and curingMycoplasmosis, Mycoplasma vaccination, and protective immunity.
Phage-Derived Depolymerase as an Antibiotic Adjuvant Against Multidrug-Resistant Acinetobacter baumannii
TLDR
The presence of a recombinant depolymerase Dpo71 from a bacteriophage specific for the gram-negative bacterium Acinetobacter baumannii in a heterologous host Escherichia coli demonstrates the feasibility of using recombinantDepolymerases as an antibiotic adjuvant to supplement the development of new antibacterials and to battle against MDR pathogens.
Light Triggered Enhancement of Antibiotic Efficacy in Biofilm Elimination Mediated by Gold-Silver Alloy Nanoparticles
TLDR
Results that AuAgNPs inhibited the formation of SDSD biofilms via distinct stress pathways that lead to the downregulation of two genes critical for biofilm production, namely, brpA-like encoding biofilm regulatory protein and fbpA fibronectin-binding protein A are provided.
Repurposing of Antibiotics: Sense or Non-sense
TLDR
Drug repurposing has been employed in order to speed up the traditional process of drug discovery by bypassing the need for toxicity testing for drugs that have been proven to be safe and effective in humans and approved by the FDA for other indications.
Clinical Epidemiology, Risk Factors, and Control Strategies of Klebsiella pneumoniae Infection
TLDR
This work highlights the epidemiology, risk factors, and control strategies against K. pneumoniae infections to highlight the grave risk posed by this pathogen and currently available options to treat Klebsiella-associated diseases.
Increased Use of Antibiotics in the Intensive Care Unit During Coronavirus Disease (COVID-19) Pandemic in a Brazilian Hospital
TLDR
Overall antimicrobial consumption in ICU has increased in the context of the COVID-19 pandemic, indicating an empirical use, which may contribute to the depletion of the therapeutic arsenal for MDR treatment.
Phage therapeutics: from promises to practices and prospectives
TLDR
The mechanism of bacteriophage treatment that makes it a real solution for multidrug-resistant infectious diseases is highlighted and significant obstacles that need to be addressed are to design better clinical studies that may contribute to the widespread use of phage therapy against multi-drug resistant pathogens.
Lactosmart: A Novel Therapeutic Molecule for Antimicrobial Defense
TLDR
It is proposed that lactosmart can be further developed as an antibacterial, antifungal, and antibiofilm agent.
Emerging Concern for Silver Nanoparticle Resistance in Acinetobacter baumannii and Other Bacteria
TLDR
Despite ample evidence of heavy metal resistance in this bacterium, little research has been dedicated to assessing the potential for NAg resistance development in A. baumannii, which is worrisome, as the increasingly indiscriminate use of NAg could promote the development of silver resistance inThis species, like what has occurred with antibiotics.
...
...